skip to main menu

hans biomed

  • CEO
  • 우리회사는
    • 국내 1호 조직은행 설립
    • 아시아 최초 FDA 등록
    • 세계일류상품 인증기업
    • 국내 최대 조직공학 연구소 보유
    • 업계최초 코스닥 상장
  • 성장연혁
  • Vision 2022
  • 사업영역
    • Allograft Tissue
    • Silicone Polymer
    • Medical Device
    • Bio Technology
  • 인증현황
  • 글로벌 네트워크
  • 찾아오시는길

HomeHans BiomedBusiness Area

Business Area

Hans Biomed Corp. was established in 1993, and was the starting company of  Wound healing and  Scar prevention  project. With the creativity, focused attention and work of our young researches, core life-saving technologies have been developed. These core technologies were then translated into novel medical products. The products developed by the Daedeok Research Center are being exported to more than 25 countries across the world.
  • Allograft Tissue
  • Silicone Polymer
  • Medical Device
  • Bio Technology

Allograft Tissue

A. Bone Transplant Products

With industrialization and increased leisure activities, the risk of bone damage is increasing. The aging population also increases the number of osteoporosis.

In such cases, the most desirable treatment is to replace the bone with bone transplant materials that are similar to the human bone to restore the skeletal structure and increase bone density to heal the damaged bone. Restoration procedures for bone damage have been performed from a long time ago, in areas of spinal surgery in neurosurgery, missing bone in orthopedics, and in dental implants. The core technology of bone restoration is bone transplant material and the processing technology, and the technological task is to provide materials or products so that it can be used safely in the hospital.

Bone transplant products that are used in patients can be applied to various settings, such as fractures from physical force or pathological fractures, in neurosurgery, orthopedic surgery or dentistry, restoration of the bone removed due to tumors, treatment of periodontal membrane disease, restoration of the jaw or facial damage. When using the bone transplant material, there is no need for secondary surgery to collect autograft bone, making the procedure more simple and reducing the costs, risks and pain associated with such secondary surgeries, as well as speeding up the treatment process.

There are approximately 20 products for dental bone transplant, including SureOss, which are supplied through Ostem Implant Corp. There are 10 or so bone products related to orthopedic or neurosurgery which are sold through Hanmi Pharmaceuticals Corp. in Korea, and which are continuously being exported overseas.

With industrialization and increased leisure activities, the risk of bone damage is increasing. The aging population also increases the number of osteoporosis.

B. Skin Transplant Products

Hans Biomed Corp. developed the core technology to recover and regenerate damaged skin tissue and to save it long term, and was the second in the world to commercialize this.

The commercialized products include the acellular dermal tissue, the SureDermTM, which is transplanted to the patient’s skin area to restore the skin, and the RegenCellTM, which is powdered form of the SureDerm, and the GPSTM and CPSTM which are biological wound dressing materials. These commercialized products have a wide range of applications, including burns, bed sores, diabetic ulcers, long-standing ulcers, cartilage damage, trauma patients, amputation patients and plastic surgery patients.

This is being most widely used in burns patients who were in pain previously due to no other treatment alternatives. It is also being used for patients from natural disasters, road accidents, congenital diseases, periodontal disease, urinary incontinence as well as all reconstruction, cosmetic surgery, dermatology, obstetrics and gynecology, orthopedics, periodontal surgery and general surgery patients in Korea.

1.Approval to establish the first tissue bank of Korea, 2.Registration in the U.S. FDA,3.The largest tissue technology research center of Korea (Hans Daedeok Research Center) and production facilities ,4.The second in the world and the first in Asia to develop skin and bone transplant materials, World’s best product producing business approval

 

Hans Biomed Corp. developed the core technology to recover and regenerate damaged skin tissue and to save it long term, and was the second in the world to commercialize this.